Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

NKTX


Fundamental

Company: Nkarta Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -1.51
Insider Own: 26.49%
Shs Outstand: 70.96M
Perf Week: 14.29%
Market Cap: 147.59M
Forward P/E: -
EPS next Y: -1.29
Insider Trans: -0.01%
Shs Float: 52.16M
Perf Month: 17.51%
Enterprise Value: -39.01M
PEG: -
EPS next Q: -0.35
Inst Own: 75.77%
Short Float: 14.45%
Perf Quarter: 12.43%
Income: -111.25M
P/S: -
EPS this Y: 10.68%
Inst Trans: -1.07%
Short Ratio: 14.33
Perf Half Y: -15.79%
Sales: 0.00M
P/B: 0.39
EPS next Y Percentage: 9.50%
ROA: -21.24%
Short Interest: 7.54M
Perf YTD: -16.47%
Book/sh: 5.34
P/C: 0.56
EPS next 5Y: -0.26%
ROE: -26.10%
52W High: 7.24 -71.27%
Perf Year: -68.72%
Cash/sh: 3.74
P/FCF: -
EPS past 3/5Y: 15.10% -19.86%
ROIC: -24.63%
52W Low: 1.31 58.78%
Perf 3Y: -85.34%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: -
Volatility W: 8.43%
Volatility M: 5.85%
Perf 5Y: -94.31%
Dividend TTM: -
EV/Sales: -
EPS Y/Y TTM: 35.73%
Oper. Margin: -
ATR (14): 0.11
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 14.48
Sales Y/Y TTM: -
Profit Margin: -
RSI (14): 65.07
Recom: 1.29
Dividend Gr. 3/5Y: - -
Current Ratio: 14.48
EPS Q/Q: 25.70%
SMA20: 15.11%
Beta: 0.71
Target Price: 12.80
Payout: -
Debt/Eq: 0.21
Sales Q/Q: -
SMA50: 14.40%
Rel Volume: 1.36
Prev Close: 1.92
Employees: 157
LT Debt/Eq: 0.19
Earnings: May 14 AMC
SMA200: -9.07%
Avg Volume: 525.68K
Price: 2.08
IPO: Jul 10, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: -1.01% -
Trades:
Volume: 715,174
Change: 8.33%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z